Skip to main content
Clinical Trials/ISRCTN11203922
ISRCTN11203922
Completed
未知

europsychological Evaluation and Rehabilitation in Multiple Sclerosis (NEuRoMS): multicentre feasibility randomised controlled trial and fidelity evaluation (Phase 2: Work Package 3 feasibility study)

ottinghamshire Healthcare NHS Foundation Trust0 sites2,354 target enrollmentFebruary 9, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Multiple sclerosis
Sponsor
ottinghamshire Healthcare NHS Foundation Trust
Enrollment
2354
Status
Completed
Last Updated
last year

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35690797/ (added 13/06/2022)

Registry
who.int
Start Date
February 9, 2021
End Date
September 30, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ottinghamshire Healthcare NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 21/07/2022:
  • All individuals:
  • Able and willing to give consent and able to communicate in English. Participant information sheets can be provided in Welsh upon request but the standardised materials and tests to be used require communication in English since these have not yet been developed for other languages.
  • Part 1 – testing the cognitive screening pathway:
  • People with MS:
  • 1\. Diagnosis of MS
  • 2\. Aged 18 years or above
  • Part 2 – acceptability, feasibility RCT and fidelity evaluation:
  • People with MS:
  • 1\. Diagnosis of MS

Exclusion Criteria

  • Part 2 participants only:
  • 1\. Currently receiving neuropsychological intervention for cognitive problems
  • 2\. Received NEuRoMS intervention during WP2ii
  • All participants:
  • 1\. Does not have the mental capacity to consent to take part in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials